Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B By Washington Examiner FacebookTwitterWhatsAppLinkedinEmailPrint February 18, 2014 12:04 pm FacebookTwitterWhatsAppLinkedinEmailPrint NEW YORK (AP) — Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B. TagsPharmaceutical Industry Related Content Faith, Freedom & Self-Reliance Shut down the enhanced Obamacare subsidies, not the government Sports Trump reveals date for UFC fight at White House White House Trump promises pay raise for Navy and armed services as shutdown continues White House Trump radios in from USS George HW Bush on Navy’s 250th anniversary White House Harris repeats false claim 2024 was ‘closest’ election in 21st century
